LD-2 disclosure · 2nd Quarter - Termination
NOVAVAX, INC.
Client
- Name
- NOVAVAX, INC.
- Description
- biotechnology company
- Location
- Maryland · United States of America
Registrant
- Description
- lobbying firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesHealth Issues
Issues related to COVID-19 vaccines.
LobbyistsMATHEW LAPINSKI · JASON BENJAMIN VAN PELT · JASON GLEASON · JOHN BREAUX · STEPHANIE LEGER · BRITTANY JOHNSON HERNANDEZ · ms CHERYL LYNN JAEGER · ms IVELISSE ALEXANDRA PORROA-GARCIA
TargetedSENATE · HOUSE OF REPRESENTATIVES
Budget/Appropriations
FY2025 Budget Reconciliation Process; all bio-pharmaceutical related provisions.
LobbyistsMATHEW LAPINSKI · JASON BENJAMIN VAN PELT · JASON GLEASON · JOHN BREAUX · STEPHANIE LEGER · BRITTANY JOHNSON HERNANDEZ · ms CHERYL LYNN JAEGER · ms IVELISSE ALEXANDRA PORROA-GARCIA
TargetedSENATE · HOUSE OF REPRESENTATIVES
Trade (domestic/foreign)
Issues related to tariffs.
LobbyistsMATHEW LAPINSKI · JASON BENJAMIN VAN PELT · JASON GLEASON · JOHN BREAUX · STEPHANIE LEGER · BRITTANY JOHNSON HERNANDEZ · ms CHERYL LYNN JAEGER · ms IVELISSE ALEXANDRA PORROA-GARCIA
TargetedSENATE · HOUSE OF REPRESENTATIVES